Showing 1721-1730 of 3070 results for "".
- Octane Aesthetics Tech Forum Panelists React to FDA Approval of Oral Semaglutidehttps://modernaesthetics.com/news/octane-aesthetics-tech-forum-panelists-react-to-fda-approval-of-oral-semaglutide/2485572/At the 2026 Octane Aesthetics Tech Forum, panelists weighed in on the recent FDA approval of oral semaglutide, offering a mix of cautious optimism and clinical realism. While the approval marks a milestone in expanding GLP-1 receptor agonist (RA) access, most experts on the panel said oral versio
- Octane Aesthetics Tech Forum: Panelists Discuss Innovation in Hair Loss Delivery, Regulationhttps://modernaesthetics.com/news/octane-aesthetics-tech-forum-panelists-discuss-innovation-in-hair-loss-delivery-regulation/2485561/The future of hair restoration may be rooted in regenerative science, but panelists at the Octane Aesthetics Tech Forum agree: the real-world success of these advances hinges on how treatments are delivered and how they’re regulated. Speaking during the “Hiding in the Shadows of H
- Octane Aesthetics Tech Forum: Clinical Strategies for Managing Rapid Weight Loss in Aestheticshttps://modernaesthetics.com/news/octane-aesthetics-tech-forum-clinical-strategies-for-managing-rapid-weight-loss-in-aesthetics/2485537/The widespread use of GLP-1 receptor agonists (GLP-1 RAs) is ushering in a new era of aesthetic medicine that demands a more nuanced approach to skin aging, hormonal health, and treatment planning. That was the consensus from a panel of aesthetic surgeons and regenerative medicine experts
- Octane Aesthetics Tech Forum: 3 Big Trends from GuidePoint Qsight’s 2025 Market Analysishttps://modernaesthetics.com/news/octane-aesthetics-tech-forum-3-big-trends-from-guidepoint-qsights-2025-market-analysis/2485514/At the 2026 Octane Aesthetic Tech Forum, Erik Haines, Managing Director of Guidepoint Qsight, presented a data-rich snapshot of the state of the medical aesthetics industry. Drawing from over $17 billion in transactional data across 45,000 aesthetic practices and millions of patient records, Hain
- Tranexamic Acid in Tumescent Solution Reduces Bruising and Pain After Arm Liposuctionhttps://modernaesthetics.com/news/tranexamic-acid-in-tumescent-solution-reduces-bruising-and-pain-after-arm-liposuction/2485477/New research indicates tranexamic acid (TXA) reduced early postoperative pain and ecchymosis when added to tumescent solution during arm liposuction. The researchers, publishing in Plastic and Reconstructive Surgery, conducted a double-blind, randomized contralateral study that in
- Octane Aesthetics Tech Forum: GLP-1 Receptor Agonists Are Reshaping Consumer Behavior and Aesthetic Business Modelshttps://modernaesthetics.com/news/octane-aesthetics-tech-forum-glp-1-receptor-agonists-are-reshaping-consumer-behavior-and-aesthetic-business-models/2485431/The rise of GLP-1 receptor agonist (GLP-1RA) medications is doing more than transforming bodies; it is reshaping the very business of aesthetics. At the 2026 Octane Aesthetics Tech Forum, panelists described how GLP-1RAs are influencing patient behavior, redefining value propositions, and catalyz
- Podium Introduces Artificial Intelligence Operating System Designed for Aesthetic Practiceshttps://modernaesthetics.com/news/podium-introduces-artificial-intelligence-operating-system-designed-for-aesthetic-practices/2485420/Podium has announced the launch of an artificial intelligence (AI)–driven operating system designed specifically for aesthetic practices, positioning the platform as a unified alternative to the fragmented software ecosystems common in cosmetic dermatology practices. The company describes the pro
- AAFPRS President Outlines “Three Rs” of Facial Plastic Surgeryhttps://modernaesthetics.com/news/aafprs-president-outlines-three-rs-of-facial-plastic-surgery/2485394/As patient interest in facial aesthetic and reconstructive procedures continues to grow, the American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS) is emphasizing the importance of specialty training through a new public education framework: the “Three Rs of the AAFPRS:” rhinoplas
- skinbetter science® Marks 10 Years of AlphaRet® Technology in Retinoid-AHA Skincarehttps://modernaesthetics.com/news/skinbetter-science-marks-10-years-of-alpharet-technology-in-retinoid-aha-skincare/2485358/skinbetter science® is marking the 10-year anniversary of its proprietary AlphaRet® technology, introduced in 2016 as one of the first topical skincare formulas to combine a retinoid with an alpha hydroxy acid (AHA). The combination, used in the flagship AlphaRet Overnight Cream, was designed to
- BIOCORNEUM® Launches Dual-Action Bruise Care System for Aesthetic Procedure Recoveryhttps://modernaesthetics.com/news/biocorneum-launches-dual-action-bruise-care-system-for-aesthetic-procedure-recovery/2485357/BIOCORNEUM® announced the release of a new Bruise Care System designed to support patients undergoing cosmetic and dermatologic procedures. The system combines a topical cream and an oral supplement to address bruising and inflammation from both internal and external pathways. The dual-com